A small molecule inhibits HCV replication and alters NS4B’s subcellular distribution

Hepatitis C Virus (HCV) is a leading cause of liver disease and represents a significant public health challenge. Treatments for this disease are inadequate and improved antiviral therapies are necessary. Several such antivirals are in development, most of which target the well-characterized NS3 pro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bryson, Paul D., Cho, Nam-Joon, Einav, Shirit, Lee, Choongho, Tai, Vincent, Bechtel, Jill, Sivaraja, Mohan, Roberts, Chris, Schmitz, Uli, Glenn, Jeffrey S.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3909674/
https://ncbi.nlm.nih.gov/pubmed/20363257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2010.03.013
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares